株式会社メディネット

Cancer immuno-cell therapy is an advanced medical practice.

Operating in medtech based in Tokyo, Japan, 株式会社メディネット operates.

Profile

"株式会社メディネット is a pioneering Medtech company specializing in cancer immuno-cell therapy, an advanced medical practice. Offering services in cell processing for immunotherapy, MEDINET supports the development and processing of cells used in cancer immunotherapy. Additionally, the company undertakes the manufacturing of specific cell products for regenerative and cell-based medical treatments. MEDINET also provides contract manufacturing services for regenerative medical products and investigational products, as well as support for facility operations and cell processing technician dispatch to ensure smooth operations for customers in regenerative and cell-based medicine. With a commitment to advancing cancer treatment, MEDINET operates a self-cancer tissue bank, collecting cancer tissues from patients for future therapeutic purposes. Partnering with medical institutions nationwide, MEDINET introduces healthcare facilities offering immunotherapy using the company's cutting-edge technology."

Its activity falls under medtech; the profile below is assembled from public directory data.

Tokyo, Japan is where the company is located.

Its current recorded stage is Plug and Play portfolio startup.

Website: www.medinet-inc.co.jp